SHANG.FOS.PHARM.GR.H YC 1 Net Asset Quality Index
SHANG.FOS.PHARM.GR.H YC 1 net asset quality index. SHANG.FOS.PHARM.GR.H YC 1 (08HH) has a Net Asset Quality Index of 51.8% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €122.97 Billion minus total liabilities of €59.30 Billion yields net assets of €63.67 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check SHANG.FOS.PHARM.GR.H YC 1 (08HH) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of SHANG.FOS.PHARM.GR.H YC 1 (2021–2025)
Net asset quality index of SHANG.FOS.PHARM.GR.H YC 1 from 2021 to 2025. This chart shows how SHANG.FOS.PHARM.GR.H YC 1's Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of March 2026, the index stands at 51.8%, representing net assets of €63.67 Billion against total assets of €122.97 Billion EUR. See SHANG.FOS.PHARM.GR.H YC 1 book value and equity for net asset value and shareholders' equity analysis.
SHANG.FOS.PHARM.GR.H YC 1 Net Asset Quality Index by Year (2021–2025)
SHANG.FOS.PHARM.GR.H YC 1 net asset quality index by year from 2021 to 2025. The table below presents the year-by-year Net Asset Quality Index for SHANG.FOS.PHARM.GR.H YC 1 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see SHANG.FOS.PHARM.GR.H YC 1 stock valuation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 51.5% | €61.84 Billion | €120.05 Billion | €58.21 Billion | ▲ +0.5 pp |
| 2024 | 51.0% | €59.93 Billion | €117.46 Billion | €57.53 Billion | ▲ +1.1 pp |
| 2023 | 49.9% | €56.62 Billion | €113.47 Billion | €56.85 Billion | ▼ -0.6 pp |
| 2022 | 50.5% | €54.11 Billion | €107.16 Billion | €53.05 Billion | ▼ -1.4 pp |
| 2021 | 51.9% | €48.38 Billion | €93.31 Billion | €44.93 Billion | — |